EditCo Bio and Telegraph Hill Partners Acquire Synthego's Engineered Cell Solutions Business to Enable Cellular Research
Mar 27, 2024•over 1 year ago
Acquiring Company
EditCo Bio
Acquired Company
EditCo Bio
Gilze Rijen Air BaseGilze Rijen Air BaseDescription
EditCo Bio, Inc., with the support of life sciences investment firm Telegraph Hill Partners, has acquired Synthego's engineered cell solutions business. This acquisition enables EditCo to further its mission of providing high-quality, easily accessible reagents for cellular research, with a focus on the rapidly expanding CRISPR market.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed